← All Sponsors
SPONSOR

Pharmacosmos A/S

Total Trials
1
Recruiting
1
Phases
Phase 4
Conditions studied: Extensive-stage Small-cell Lung Cancer
NCT05874401 Phase 4
Recruiting

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Extensive-stage Small-cell Lung Cancer
Spain View Trial →